The presence of the PD-1 ligands (PD-L1 and PD-L2) on the membrane of tumor cells has been shown to be an important and obvious, but not definitive, biomarker for predicting a tumor response to PD-1 blockade [33, 35]. The gene discussed is PDCD1; the disease is neoplasm.